Personalized Breast and Lung Cancer Care
Requirements
- Basic understanding of cancer biology and treatment modalities.
- Familiarity with medical terminology related to breast and lung cancer.
- Access to a computer or mobile device with internet connectivity for accessing course materials.
- Eagerness to learn about personalized medicine and its application in cancer care.
- No prior experience in oncology or personalized medicine is necessary, as the course is designed to accommodate learners of all levels, including beginners.
Description
"Personalized Breast and Lung Cancer Care" offers examination of the evolving landscape of cancer treatment, focusing on the intersection of molecular diagnostics, precision medicine, and holistic patient care.
Participants will gain insights into the epidemiological impact of lung cancer, with a focus on early detection and standard NSCLC treatment. The course also explores future perspectives in lung cancer surgery research, emphasizing advancements in segmentectomy procedures and the role of randomized controlled trials. Additionally, there is an advocacy for investment in innovative technologies, and the development of young talent in lung cancer surgical research, with a specific focus on understanding the heterogeneity of NSCLC and the importance of actionable biomarkers in treatment decisions.
In breast cancer management, the course emphasizes the role of molecular diagnostics and personalized treatment strategies. Participants will delve into Next-Generation Sequencing (NGS) technology, tumor gene-expression signatures, and predictive markers, gaining a comprehensive understanding of tailored therapies for breast cancer.
Throughout the program, emphasis is placed on the transformative potential of personalized oncology and cancer diagnostics in driving medical innovation. Participants engage with emerging therapies, precision radiotherapies, and the integration of Artificial Intelligence, fostering a nuanced understanding of the evolving landscape of cancer care.
By fostering dialogue and collaboration among healthcare professionals, researchers, and students, "Personalized Breast and Lung Cancer Care" aims to catalyze advancements in cancer treatment, ultimately improving patient outcomes and quality of life.
Who this course is for:
- Ideal for policymakers, stakeholders, and those interested in the intersection of science, policy, and healthcare innovation.
- Suitable for both experienced policymakers and newcomers to the field seeking valuable insights into healthcare policy and personalized medicine.
Instructor
- 4.1 Instructor Rating
- 8 Reviews
- 477 Students
- 5 Courses
Prof. Denis Horgan, a distinguished leader in policy and governmental affairs, brings over 15 years of experience in driving transformative change in healthcare systems. As the former Director of the European Cancer Patient Coalition and Executive Director of the European Alliance of Personalised Medicine, Prof. Horgan has spearheaded numerous initiatives to advance the adoption of personalized healthcare across the EU. With a robust background in academia, including the publication of over 50 academic articles, Prof. Horgan is a renowned expert in the field of personalized medicine. His passion for innovation and commitment to improving healthcare outcomes make him a dynamic and influential figure in the global healthcare community.